CSL Behring SA
36.4 FTEThe score of CSL Behring shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +53 % Equity +71 % Total assets +100 % Headcount (avg FTE) +16 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 11 financial years; a free account shows 2. →CSL Behring's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 19 Dec 2025
- Year ended 30 Jun 2024filed on 18 Dec 2024
- Year ended 30 Jun 2023filed on 20 Nov 2023
- Year ended 30 Jun 2022filed on 15 Dec 2022
- Year ended 30 Jun 2021filed on 20 Dec 2021
CSL Behring's financial analysis
- Solvency52.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CSL Behring
CSL Behring's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.483.701
- VAT number
- BE0454483701
- Peppol
- Registered · 0208:0454483701 · as of 29 Oct 2026
- Legal form
- SA
- Incorporated
- 15 Feb 1995
- Registered office
- 2800 Mechelen
- Size
- Small · 36.4 FTE
- Latest accounts
- 2025 · filed on 19 Dec 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
CSL Behring (SA) has been based in Mechelen since 1995, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €184.4m, a net profit of €9.00m and equity of €48.3m. With 36.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 52.4%, above the median of its sector (46.0%).
Companies similar to CSL Behring
Companies in the same business, of comparable size and area, outside its group.
- Nipro Medical Europe Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €324.7m
- Chiesi Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €32.4m
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- Centre Europeen DE Repartition Pharmaceutique Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €127.7m
- Livlina Wholesale of pharmaceutical and medical goods Sint-Niklaas · balance sheet €82.9m
- Medtronic Belgium Wholesale of pharmaceutical and medical goods Jette · balance sheet €110.4m
- sandoz Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €55.3m
Frequently asked questions about CSL Behring
What is the revenue of CSL Behring?
According to the 2025 annual accounts filed with the NBB, the revenue of CSL Behring amounts to 184,436,093 €.
What is the VAT number of CSL Behring?
In Belgium, the VAT number is the company number prefixed with BE: BE0454483701 for CSL Behring, if the company is VAT-registered. Its company number (CBE) is 0454.483.701.
Where is the registered office of CSL Behring?
According to the CBE register, the registered office of CSL Behring is in 2800 Mechelen.
What is the equity of CSL Behring?
At the close of the 2025 financial year, the equity of CSL Behring amounts to 48,258,521 €, a solvency of 52.4% of total assets.
How many people work at CSL Behring?
36.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages CSL Behring?
The register lists 3 active mandates at CSL Behring. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CSL Behring
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →